Skip to main content
Premium Trial:

Request an Annual Quote

Responding to Coronavirus Test Shortage, FDA Lets NY State Health Department Authorize Assays

NEW YORK – Responding to a severe shortage of tests for the novel coronavirus in the state of New York, the US Food and Drug Administration on Thursday gave the New York State Department of Health permission to authorize New York laboratories to begin patient testing.

In a statement issued on Friday, the agency said it is "not objecting" to the NYSDOH's approach, under which labs need to provide validation data to the health department within 15 days of starting testing instead of having to pursue an Emergency Use Authorization with the FDA.

FDA said its decision was based on the fact that NYSDOH "has a long-established framework in place for [the] oversight of laboratory-developed tests in New York State" and that it has previously accredited the health department's Wadsworth Center in Albany as a third-party reviewer for certain molecular tests.

"This NYSDOH action shows the FDA's extreme flexibility and adaptability during times of public health emergencies," said FDA Commissioner Stephen Hahn in a statement, adding that New York labs "will interact solely with NYSDOH, which should expedite the availability of patient testing in New York State."

New York's governor Andrew Cuomo said on Thursday that the state is partnering with 28 private labs over the next several weeks and that the first drive-through testing facility will open in New Rochelle on Friday. He also said that the state is contracting with Opko Health's BioReference Laboratories to provide testing for this and other locations. BioReference plans to offer 5,000 tests per day, which will become available next week.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.